41 New Patients Recorded
June finished 10 below May’s 51, but it still landed 17 above June 2025, keeping patient acquisition ahead of last year’s June result.
June closed with 41 new patients, 19 patient-related opportunities, and 23 patient-related calls. New patient volume stayed well ahead of last June, while clearer channel attribution remains the main opportunity in the lead pipeline.
Summary
June finished 10 below May’s 51, but it still landed 17 above June 2025, keeping patient acquisition ahead of last year’s June result.
June produced 19 patient-related opportunities and 23 patient-related calls, showing steady incoming demand across both leads and calls.
13 of the 19 patient-related opportunities were left without a source, which limits how clearly channel contribution can be measured.
Website visitors came in at 1.79K, down 9.05% versus the previous 30 days, with traffic spread across paid, landing page, organic, referral, and a sizable unlabelled traffic bucket.
Learned
The month eased after May’s peak, but the year-on-year lift shows demand has not weakened overall. June still performed like a stronger acquisition month than the same point last year.
June did not point to a shortage of intent. The clearer issue was visibility, with enough booking-ready demand present to convert, but not enough source clarity to confidently trace where that intent was coming from.
Phone responsiveness held up well, which suggests the main growth opportunity is not basic call coverage. The stronger upside is converting and classifying inbound demand more cleanly after first contact.
Paid search and paid social were both still doing their jobs at the top of the funnel. Search kept capturing active intent, while social continued widening awareness around the strongest patient-facing offer themes.
NPN
Monthly history across 2023 to 2026 provides the context for June's result.
| Month | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| January | 19 | 28 | 57 | 48 |
| February | 28 | 26 | 56 | 31 |
| March | 36 | 21 | 29 | 51 |
| April | 18 | 22 | 27 | 41 |
| May | 29 | 28 | 26 | 51 |
| June | 22 | 32 | 24 | 41 |
| July | 28 | 34 | 26 | - |
| August | 24 | 15 | 33 | - |
| September | 28 | 42 | 25 | - |
| October | 13 | 25 | 22 | - |
| November | 33 | 40 | 43 | - |
| December | 29 | 16 | 50 | - |
June finished 28.1% above the previous June high, which shows mid-year patient demand is now landing at a meaningfully stronger level than in prior years.
June was down 19.6% from May, but because it still matched April and sat 32.3% above February, the result reads more like a pullback from a peak than a loss of momentum.
The stronger signal is the 70.8% year-on-year lift, which suggests the practice is converting a much deeper pool of demand than it was at the same point last year.
The first half of 2026 is up 20.1% on the same period in 2025, and with 5 of 6 months at 41 or higher, growth is being sustained across the year rather than carried by one spike.
Leads
These markers are shown as a share of the 19 patient-related opportunities recorded for the month.
The biggest story in June was not low demand, but low source clarity across the lead mix.
11 opportunities sat in Not Interested, but 8 still moved into booked, attended, or treatment-done stages.
The rebound from May suggests softer lead volume did not continue into June. Demand reopened rather than flattening, which is a healthier sign than a one-month dip turning into a trend.
A meaningful share of June enquiries moved forward, which indicates lead quality was workable. The bigger drag was the large not-interested group, pointing more to qualification fit and follow-up precision than weak interest across the board.
The unlabelled majority makes optimisation harder because the strongest channel may be under-credited. That creates risk of making spend decisions with an incomplete picture of which enquiries are actually producing patient intent.
Calls
The lift in calls alongside higher opportunity volume points to a broader rise in inbound intent, not just an isolated spike on the phones. More people were actively reaching out across multiple contact paths.
Coverage remained strong enough that missed calls were unlikely to be the main reason demand leaked. That shifts attention back toward what happened after contact, rather than whether the practice was reachable.
The Google Ads line dominated the call mix, which suggests search intent is skewing toward phone-first behaviour. That matters because paid search performance should be judged not only by form fills, but by how well call-driven demand is converted.
Google Ads
Search demand did not fall away after May. The account still attracted active intent, which supports the broader pattern of stronger calls and opportunities during June.
Cost pressure rose faster than traffic volume, which usually signals a more competitive auction or a heavier push into pricier searches. June still captured demand, but it did so with less cost efficiency than May.
Because calls and leads both strengthened, the higher spend was still supporting real enquiry flow. The real limitation is attribution confidence, which makes it harder to separate expensive clicks from genuinely valuable patient outcomes.
Meta Ads
June’s standout creative by both reach and click volume.
A strong treatment-focused video with efficient click performance.
Implant-led creative that continued attracting meaningful interest.
Routine care messaging still delivered solid attention and value.
June’s Meta performance points to a clear creative hierarchy. The strongest response sat with offer-led messaging, which suggests patient acquisition hooks are still the fastest way to win attention on social.
Treatment-focused creatives still added value, but they behaved more like trust-building support than the main demand driver. That makes them useful for breadth, while the offer-led angle does the heavier acquisition work.
With CPC still below A$1 and CPM improving, the platform remained efficient enough to keep feeding awareness without needing to carry the full conversion burden on its own.
Website
June’s traffic mix was broad enough that the website was not leaning on a single acquisition source. Visibility was being maintained across paid, landing-page, organic, and unlabelled traffic at the same time.
The softer total visitor count matters, but the more important read is that discovery remained diversified. The next opportunity is less about rebuilding traffic from zero and more about converting that mixed traffic into clearer enquiry outcomes.
GBP
Landing Page
This page continues to support paid and campaign-led traffic capture during the period.
This page remains relevant for offer-led acquisition and conversion support.
Wins
June did not need to match May’s peak to remain a strong acquisition month. Staying well ahead of last year shows the practice is operating from a healthier patient demand base.
Growth appeared across both CRM opportunities and phone enquiries, which is a stronger sign than improvement in only one channel. Demand was showing up in more than one place.
Search kept capturing active intent while social continued expanding reach efficiently, giving the account both demand capture and audience-building momentum in the same month.
Local discovery and website traffic were both still producing action, which means June’s visibility was not confined to one platform or one user path.
Next Steps
Reducing the unlabelled lead share is the clearest reporting improvement available because it will make campaign impact easier to read and optimise.
June showed 8 ready-to-book opportunities and 17 first-time callers, so fast handling at first contact remains important.
Continue leaning into the patient-acquisition messages that are already proving effective, especially the New Patient Offer and stronger treatment-focused Meta creatives.
Website traffic and GBP activity both remained meaningful in June, so the next priority is making sure those visits turn into clearly tracked leads.